Does OLAPARIB Cause Metastases to liver? 174 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Metastases to liver have been filed in association with OLAPARIB (Lynparza). This represents 1.0% of all adverse event reports for OLAPARIB.
174
Reports of Metastases to liver with OLAPARIB
1.0%
of all OLAPARIB reports
43
Deaths
28
Hospitalizations
How Dangerous Is Metastases to liver From OLAPARIB?
Of the 174 reports, 43 (24.7%) resulted in death, 28 (16.1%) required hospitalization, and 6 (3.4%) were considered life-threatening.
Is Metastases to liver Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Metastases to liver?
LETROZOLE (1,295)
FULVESTRANT (1,241)
CAPECITABINE (1,061)
EVEROLIMUS (1,020)
RIBOCICLIB (967)
PACLITAXEL (885)
OCTREOTIDE (774)
BEVACIZUMAB (707)
FLUOROURACIL (630)
TAMOXIFEN (595)
Which OLAPARIB Alternatives Have Lower Metastases to liver Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL